Biotech

Capitalist Countdown: Wealthy VC’s Top 5 Investing News Stories of the Week

The Capitalist Countdown is a weekly series that features the biggest stories from the market’s hottest stocks as well as news from…

Read More »

Pfizer Begins Testing Omicron-Targeting Vaccine

Despite two out of three U.S. adults being fully vaccinated, we are still experiencing some of the highest infection rates…

Read More »

Capitalist Countdown: Wealthy VC’s Top 5 Investing News Stories of the Week

The Capitalist Countdown is a weekly series that features the biggest stories from the market’s hottest stocks as well as…

Read More »

Vaccine Stocks Rise Sharply as New Omicron Variant Has Big Pharma Licking Its Chops

Since the omicron variant, which originated in southern Africa, began popping up in various countries worldwide, the S&P 500 (SPX)…

Read More »

Capitalist Countdown: Wealthy VC’s Top 5 Investing News Stories of the Week

The Capitalist Countdown is a weekly series that features the biggest stories from the market’s hottest stocks as well as news from…

Read More »

After a Breakout Year in 2021, Here’s Why Regeneron Stock Has Even More Upside

For the Millions of Americans That Have Been Infected With COVID-19, Few Therapeutics Have Been More Effective at Treating the…

Read More »

Pfizer Says its New COVID Pill Cuts Risks of Hospitalization, Death By 90%

Different from vaccines, which are administered with a shot and provide immunity via antibody development, many of the new COVID…

Read More »

Capitalist Countdown: Wealthy VC’s Top 5 Investing News Stories of the Week

The Capitalist Countdown is a weekly series that features the biggest stories from the market’s hottest stocks as well as news from…

Read More »

Capitalist Countdown: Wealthy VC’s Top 5 Investing News Stories of the Week

The Capitalist Countdown is a weekly series that features the biggest stories from the market’s hottest stocks as well as…

Read More »

Johnson & Johnson Kicks Off Big Pharma’s Q3 Earnings SZN

Johnson & Johnson (NYSE: JNJ) reported its Q3 2021 earnings on October 19th and beat EPS estimates by nearly 10%.…

Read More »
Back to top button